Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
813.00    5.00 (0.62%)
Bid:
812.00
Ask:
813.00
Spread: 1.00 (0.123%)
Market Cap: £1.13b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

14 May 2025 07:00

RNS Number : 5368I
Savills PLC
14 May 2025
 

14 May 2025

SAVILLS PLC

 

("Savills" or "the Company")

 

Trading update

 

Ahead of its Annual General Meeting (AGM) to be held at 12 noon today at Savills, 33 Margaret Street, London W1G 0JD, Savills plc, the international real estate advisor issues the following trading update:

 

Savills has traded broadly in line with our expectations in the first quarter and for the year to date, and comfortably ahead of the comparable period last year. 

 

Highlights:

 

· Our global capital transaction revenue improved (+7% in Q1), particularly in EMEA and, with some exceptions, values are largely recalibrated in most prime markets. There is renewed investor interest in prime core office stock throughout Europe.

· Leasing revenues grew over 20% in Q1 as markets have continued to be more active across most sectors.

· Most prime residential markets have remained resilient through Q1 with the UK performing better than last year in advance of the increase in Stamp Duty.

· Savills less transactional businesses (Property Management, Investment Management and Consultancy) have performed as expected, with a particularly strong performance in Consultancy.

· The uncertainty created by recent macro-economic and geopolitical events has resulted in a short term slow-down in global transaction activity, which we expect to recover as sentiment becomes more certain.

· The Group's underlying pipeline of potential transactions is significantly improved compared with the same time last year.

 

Our less transactional businesses continue to provide a solid platform for the Group with a resilient earnings stream. Meanwhile on the transactional side, there remains significant investor interest in the secure income characteristics of real estate, and in most major cities the office market is seeing much greater investor demand.

 

Outlook

 

We continue to develop our business through selective recruitment and acquisitions, supported by a strong balance sheet.

 

We expect that the impact of tariffs on the execution of transactions in Q2 means that Savills H1 performance may be largely similar to last year, however we anticipate continued improvement in market conditions through the second half of the year.

 

The Group's Half Year Results for the six months to 30 June will be announced on 14 August 2025.

 

Mark Ridley, Chief Executive, commented:

 

"We have had a good start to the year with performance comfortably ahead of the prior year, reflecting progressive recovery in most markets. The current macro-level uncertainty is clearly having a near term impact on transactional activity, as investors and corporates digest the potential effects of recent events. However, I am confident that the underlying trajectories for our transactional businesses are substantially improved year-on-year. I am delighted with the performance of our teams worldwide in helping clients navigate these circumstances and in seeking longer term business development initiatives, which our strong balance sheet enables us to pursue."

 

 

 

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Teneo 020 7353 4200

Elizabeth Snow

Jo Blackshaw

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSAEDIVLIE
Date   Source Headline
1st Feb 202411:00 amRNSTotal Voting Rights
22nd Jan 20249:11 amRNSBlock listing Interim Review
11th Jan 20244:02 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNSYear End Trading Update
2nd Jan 202412:33 pmRNSTotal Voting Rights
15th Dec 202310:00 amRNSAdditional Listing
14th Dec 202312:56 pmRNSDirector/PDMR Shareholding
13th Dec 202311:42 amRNSNon-Executive Director Appointment
13th Nov 20232:02 pmRNSSAVILLS APPOINTS NEW CEO OF SAVILLS NORTH AMERICA
13th Nov 202312:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20233:16 pmRNSForm 8.3 - OntheMarket PLC
1st Nov 202310:00 amRNSTotal Voting Rights
27th Oct 202310:00 amRNSAdditional Listing
12th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20238:50 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSAdditional Listing
12th Sep 20235:10 pmRNSTotal Voting Rights
1st Sep 202311:00 amRNSTotal Voting Rights
18th Aug 20232:00 pmRNSAdditional Listing
15th Aug 20234:06 pmRNSBlock listing Interim Review
14th Aug 20232:05 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSChair Succession
10th Aug 20237:00 amRNSHalf-year Report
21st Jul 202310:00 amRNSBlock listing Interim Review
11th Jul 202312:50 pmRNSDirector/PDMR Shareholding
4th Jul 20239:20 amRNSTotal Voting Rights
13th Jun 20235:31 pmRNSDirector/PDMR Shareholding
1st Jun 202310:00 amRNSTotal Voting Rights
17th May 20234:05 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Statement
11th May 20236:12 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20235:15 pmRNSDirector/PDMR Shareholding
12th Apr 20232:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:15 pmRNSAnnual Report and AGM Notice
30th Mar 20237:47 amRNSAdditional Listing
16th Mar 20237:00 amRNSFinal Results
14th Mar 20235:07 pmRNSHolding(s) in Company
13th Mar 202311:06 amRNSDirector/PDMR Shareholding
1st Mar 202310:00 amRNSTotal Voting Rights
16th Feb 202311:17 amRNSBlock listing Interim Review
13th Feb 20234:32 pmRNSDirector/PDMR Shareholding
23rd Jan 202312:45 pmRNSBlock listing Interim Review
12th Jan 20234:10 pmRNSDirector/PDMR Shareholding
12th Jan 20237:00 amRNSYear End Trading Update
15th Dec 202211:59 amRNSNon-Executive Director Appointment
13th Dec 20221:20 pmRNSDirector/PDMR Shareholding
2nd Dec 202211:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.